Skip to main content
OK BIOTECH logo

OK BIOTECH — Investor Relations & Filings

Ticker · 4155 ISIN · TW0004155007 TW Manufacturing
Filings indexed 1,730 across all filing types
Latest filing 2025-03-13 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 4155

About OK BIOTECH

http://www.okbiotech.com

OK Biotech Co., Ltd. is a medical device company specializing in the research, development, manufacturing, and global distribution of diagnostic and home healthcare solutions. Established in 2004, the company focuses on blood glucose monitoring systems, including high-precision meters and test strips, alongside over-the-counter (OTC) hearing aids and multiple frequency therapy devices. OK Biotech provides comprehensive services ranging from product design to complete factory setup solutions, supporting partners from initial planning through to mass production. By leveraging advanced R&D and production technologies, the company delivers reliable OEM and ODM solutions designed for both personal wellness and professional clinical applications. Its commitment to technical innovation ensures the delivery of high-quality medical instruments and tailored healthcare support to a global market.

Recent filings

Filing Released Lang Actions
代重要子公司PRODIGY DIABETES CARE, LLC. 公告現金股利配發基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from a company (4155 訊映) regarding the declaration of a cash dividend by its important subsidiary PRODIGY DIABETES CARE, LLC. It specifies the dividend amount, the record date, and related dates. The document length is only 642 characters, indicating it is a brief announcement rather than a full report. It does not contain financial statements or detailed analysis, but rather dividend payment details. According to the filing definitions, announcements about dividend amounts and payment details fall under the category 'Notice of Dividend Amount (DIV)'.
2025-03-13 Chinese
代重要子公司PRODIGY DIABETES CARE, LLC. 公告董事會決議發放現金股利
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (511 characters) about a board resolution to distribute cash dividends by a subsidiary. It specifies the dividend amount and the board meeting date. There is no detailed financial report or analysis, only a brief notice of dividend declaration. According to the definitions, announcements about dividend amounts and payment details fall under 'Notice of Dividend Amount (DIV)'. The document is not a full report but a specific dividend announcement.
2025-03-13 Chinese
本公司因會計師事務所內部輪調政策更換簽證會計師
Audit Report / Information Classification · 95% confidence The document is a short announcement from a listed company (4155 訊映) regarding a change in the signing auditors due to internal rotation policy at the accounting firm. It includes details about the old and new signing auditors and the reason for the change. There is no financial data, no full audit report, nor any detailed financial statements or analysis. The document is brief (1138 characters) and serves as a regulatory announcement about auditor change, not the audit report itself. Therefore, it fits best under Audit Report / Information (AR) category, which covers standalone audit-related announcements excluding full annual reports. Q1 2025
2025-03-11 Chinese
本公司董事會決議通過股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (764 characters) from a company (4155 訊映) regarding a board resolution on dividend distribution for the fiscal year 113 (2024). It details the cash dividend per share, total cash dividend amount, and confirms no stock dividends or capital increases. There is no detailed financial data or comprehensive report content, only a dividend decision announcement. According to the rules, such announcements about dividend amounts and payment details fall under the category 'Notice of Dividend Amount (DIV)'. The document is not a full report but a specific dividend announcement.
2025-03-11 Chinese
本公司董事會決議通過民國113年度董事酬勞及員工酬勞分派情形
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the board of directors' resolution on the distribution of directors' and employees' remuneration for the fiscal year 113 (2024). It includes specific amounts approved and notes on differences from estimated amounts in the financial report. The document is short (992 characters) and focuses on remuneration decisions rather than detailed compensation reports or full financial statements. It is not a full remuneration report (DEF 14A) but an announcement of remuneration decisions. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about remuneration decisions without detailed compensation disclosures or financial data.
2025-03-11 Chinese
本公司董事會決議召開114年股東常會相關事宜
AGM Information Classification · 95% confidence The document is a formal announcement from the company's board regarding the scheduling and agenda of the upcoming Annual General Meeting (AGM) for the year 114 (Taiwan calendar year). It includes details such as the date and location of the AGM, items to be reported, approved, and discussed, as well as procedural information like the suspension of share transfers. The document does not contain financial statements or detailed financial analysis but rather focuses on the meeting arrangements and agenda items. The length is short (1149 characters), and it is clearly an announcement about the AGM rather than the AGM materials or report itself. Therefore, it fits the category of AGM Information (AGM-R).
2025-03-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.